These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6279517)

  • 1. Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis.
    Peppler MS
    Infect Immun; 1982 Mar; 35(3):840-51. PubMed ID: 6279517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV.
    Peppler MS; Schrumpf ME
    Infect Immun; 1984 Jan; 43(1):217-23. PubMed ID: 6317566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variation and modulation in Bordetella bronchiseptica.
    Peppler MS; Schrumpf ME
    Infect Immun; 1984 Jun; 44(3):681-7. PubMed ID: 6373614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shelf life of prepared Bordet-Gengou and Regan-Lowe agar plates for isolation of Bordetella pertussis.
    Ruijs GJ; Groenendijk TW; Biever M
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):974-8. PubMed ID: 1794372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of potential virulence determinants on Bordetella bronchiseptica-induced ciliostasis.
    Bemis DA; Wilson SA
    Infect Immun; 1985 Oct; 50(1):35-42. PubMed ID: 2864315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of Bvg- variants of Bordetella pertussis].
    Passerini de Rossi BN; Friedman LE; Darnaud S; de Torres RA; Franco MA
    Rev Argent Microbiol; 1997; 29(2):75-83. PubMed ID: 9424628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Bordetella pertussis: benefits of using both Bordet-Gengou and charcoal agar media.
    Ahmad F; Calder MA
    J Clin Pathol; 1984 Sep; 37(9):1071-2. PubMed ID: 6088592
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory Maintenance of Bordetella pertussis.
    Hulbert RR; Cotter PA
    Curr Protoc Microbiol; 2009 Nov; Chapter 4():Unit 4B.1. PubMed ID: 19885941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.
    von Koenig CH; Tacken A; Finger H
    J Clin Microbiol; 1988 Dec; 26(12):2558-60. PubMed ID: 2906641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.
    Imaizumi A; Suzuki Y; Ono S; Sato H; Sato Y
    J Clin Microbiol; 1983 May; 17(5):781-6. PubMed ID: 6306047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of modified Bordet-Gengou and modified Regan-Lowe media for the isolation of Bordetella pertussis and Bordetella parapertussis.
    Kurzynski TA; Boehm DM; Rott-Petri JA; Schell RF; Allison PE
    J Clin Microbiol; 1988 Dec; 26(12):2661-3. PubMed ID: 2906642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of Bordetella pertussis by a monoclonal antibody-based colony blot assay.
    Gustafsson B; Askelöf P
    J Clin Microbiol; 1989 Apr; 27(4):628-31. PubMed ID: 2542357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of culture conditions on expression of antigens in Bordetella bronchiseptica.
    Kasprzak H; Rehak E; Krüger M
    Zentralbl Veterinarmed B; 1994 Dec; 41(10):645-53. PubMed ID: 7597857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved selective isolation of Bordetella pertussis by use of modified cyclodextrin solid medium.
    Ohtsuka M; Kikuchi K; Shundo K; Okada K; Higashide M; Sunakawa K; Hiramatsu K
    J Clin Microbiol; 2009 Dec; 47(12):4164-7. PubMed ID: 19846652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordet-Gengou agar medium supplemented with albumin-containing biologics for cultivation of bordetellae.
    Hiramatsu Y; Osada-Oka M; Horiguchi Y
    Microbiol Immunol; 2019 Dec; 63(12):513-516. PubMed ID: 31489969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-envelope proteins of Bordetella pertussis.
    Parton R; Wardlaw AC
    J Med Microbiol; 1975 Feb; 8(1):47-57. PubMed ID: 165297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change in the ultrastructure of B. pertussis cultivated on different media. I. An electron microscopic study of B. pertussis during passage and storage on Bordet-Gengou medium].
    Golubeva OS; Kushnarev VM; Glazova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):101-3. PubMed ID: 4369503
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability in derivative strains of Bordetella pertussis.
    Parker CD; Doyle S; Field LH; Hewlett E
    Dev Biol Stand; 1980; 45():119-27. PubMed ID: 6249689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth phase influences complement resistance of Bordetella pertussis.
    Barnes MG; Weiss AA
    Infect Immun; 2002 Jan; 70(1):403-6. PubMed ID: 11748208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and properties of Bordetella pertussis heat-labile toxin.
    Livey I; Wardlaw AC
    J Med Microbiol; 1984 Feb; 17(1):91-103. PubMed ID: 6319705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.